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Accumulating evidence from animal and human studies suggests that vitamin D is involved in many functions
of the human reproductive system in both genders, but no comprehensive analysis of the potential relationship
between vitamin D status and Assisted Reproduction Technologies (ART) outcomes is currently available. On this
basis, the purpose of this systematic review and meta-analysis was to perform an in-depth evaluation of clinical
studies assessing whether vitamin D status of patients undergoing ART could be related to cycle outcome variables.
This issue is of interest considering that vitamin D deficiency is easily amenable to correction and oral vitamin D
supplementation is cheap and without significant side effects. Surprisingly, no studies are currently available
assessing vitamin D status among male partners of couples undergoing ART, while seven studies on vitamin D
status of women undergoing controlled ovarian hyperstimulation (COH) for ART were found and included in the
review. Results show that vitamin D deficiency is highly prevalent among women undergoing COH, ranging from
21% to 31% across studies conducted in Western countries and reaching 75-99% in Iranian studies. Data on vitamin
D deficiency (25-hydroxyvitamin D serum levels <20 ng/ml) in relation to ART outcomes could be extracted from
three studies and included in the meta-analysis, yielding a common risk ratio (RR) of 0.89 (95% CI 0.53-1.49) and
showing a lower but not statistically significant likelihood of clinical pregnancy for vitamin-D-deficient women
compared with vitamin-D-sufficient patients. In conclusion, there is insufficient evidence to support the routine
assessment of vitamin D status to predict the clinical pregnancy rate in couples undergoing ART. The partly conflicting
results of the available studies, potentially explaining the lack of statistical significance for a negative influence of
vitamin D deficiency on clinical pregnancy rate, are likely secondary to confounders and insufficient sample size, and
further larger cohort and randomised controlled studies are required.
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Accumulating evidence from animal and human studies
suggests that vitamin D is involved in many functions of
the human reproductive system in both genders. While
crucial roles for vitamin D in human infertility, pregnancy
and neonatal growth have been extensively reviewed else-
where [1-5] no comprehensive analysis of the potential re-
lationship between vitamin D and Assisted Reproduction
Technologies (ART) outcomes is currently available. This* Correspondence: vigano.paola@hsr.it
1Department Obstetrics and Gynecology, San Raffaele Scientific Institute, Via
Olgettina 60, 20136 Milano, Italy
Full list of author information is available at the end of the article
© 2014 Vanni et al.; licensee BioMed Central L
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.is surprising considering that there is a strong rationale
for a potential role of vitamin D [4].Vitamin D and female reproductive function
A role for vitamin D in ovarian steroidogenesis is well
established [4], and recent evidence has shown an effect
of vitamin D on uterine receptivity [4,6]. Importantly,
vitamin D has also been shown to be involved in the
pathophysiology of some disorders of women of child-
bearing age that are most commonly encountered
among women undergoing In Vitro Fertilization (IVF)
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contribute to the development of insulin resistance
and impaired glucose clearance in Polycystic Ovary
Syndrome (PCOS). Indeed, even if the issue of
whether PCOS itself may be associated with altered
levels of vitamin D is still controversial, lower
25-hydroxyvitamin D [25(OH)D] levels characterise
PCOS women suffering from metabolic disturbances
including obesity, metabolic syndrome and insulin
resistance [7,8]. Consistently, especially among
PCOS patients with severe insulin resistance, a
therapeutic efficacy of supplementation with vitamin
D in improving insulin sensitivity, androgen levels,
ovarian folliculogenesis and menstrual frequency
was reported [9-11]. Surprisingly, however, no data
regarding a potential role for vitamin D status in
predicting or ameliorating IVF outcome among
women with PCOS and metabolic disturbances
are currently available.
2. Vitamin D status has recently been related to
the development of uterine leiomyomas, with
observations showing that lower 25(OH)D levels
correlate with a higher risk and a greater volume of
uterine fibroids, both in black and white ethnicities
[12,13]. These findings were also confirmed in our
study conducted in infertile women [14]. A potential
therapeutic benefit of vitamin D supplementation in
the inhibition of development and/or growth of
uterine fibroids has been consistently established both
in vitro [15-18] and in animal studies [19]. However,
no evidence is currently available addressing the
benefits of treatment with vitamin D for women
with leiomyomas, neither in the context of IVF
studies or in the general gynaecological population.
3. Endometriosis has also been associated with altered
levels of 25(OH)D. In a preliminary case–control
study by our group [20], we observed higher
serum levels in affected cases but our results were
subsequently properly questioned because we
included in the control group a high proportion of
women with leiomyomas and unexplained infertility,
two conditions that were subsequently demonstrated
to be deficient for 25(OH)D. More robust evidence
recently emerged, showing that women within
the highest quintile of predicted vitamin D
concentration had a 24% lower risk of endometriosis
than women in the lowest quintile [21].
Consistently, two animal studies have shown that
treatment with vitamin D or with a Vitamin D
Receptor (VDR) agonist can inhibit the development
of endometriotic lesions [22,23], but the hypothesis
of a beneficial effect of vitamin D supplementation
in the treatment of patients with endometriosis has
not yet been clinically tested.4. Several lines of evidence show an association
between vitamin D deficiency and Body Mass Index
(BMI). Indeed, according to a recent meta-analysis
totalling over 42,000 general adult patients, each
10% increase in BMI leads to a 4% decrease in 25
(OH)D concentrations [24]. Vitamin D deficiency
could therefore contribute to the adverse health
effects associated with obesity [24], including lower
clinical and live birth rates and higher miscarriage
rate following ART [25]. However, no studies have
so far considered the possibility of treating vitamin
D deficiency in overweight women undergoing ART
as a means of alleviating the adverse influences of
raised BMI on ART outcomes.
Vitamin D and male reproductive function
Vitamin D may play a role in human spermatogenesis.
The favourable effect of 25(OH) on human spermatozoa
has been shown in vitro [26-28] and three cross-sectional
association studies on serum 25(OH)D levels and semen
quality have been conducted in young healthy men with-
out infertility problems [27,29,30]. The results, however,
were quite discordant (Table 1). A single cross-sectional
study [31] has also investigated the relationship between
vitamin D status and semen parameters in a population of
n = 364 infertile men as compared to n = 195 age-matched
fertile controls. Interestingly, after adjustment for some
relevant confounders, statistically significant associations
were observed between 25(OH)D levels and sperm motil-
ity (Spearman’s coefficient = 0.12, p = 0.03) and morph-
ology (Spearman’s coefficient = 0.12, p = 0.03) in infertile
men (Table 1).
Based on these observations, the purpose of this sys-
tematic review and meta-analysis was to perform an
in-depth evaluation of clinical studies assessing whether
vitamin D status of patients undergoing ART could be
related to cycle outcome variables. This issue is of par-
ticular interest considering that vitamin D status may be
easily adjustable.
Review
Methods
Study selection and search strategy
The present literature overview was conducted accord-
ing to the Preferred Outcome Items for Systematic
Reviews and Meta-analysis (PRISMA statement) [32].
Literature searches were conducted to identify studies
published between January 1990 and February 2014. The
electronic databases PUBMED, EMBASE and CEN-
TRAL were searched using the following mixture of
Medical Subject Heading (MeSH) terms and keywords
terms: (‘Vitamin D’ OR ’25 (OH) D’ OR ‘1,25 (OH)2 D’
OR ‘calciferol’ OR ‘ergocalciferol’ OR ‘cholecalciferol’ OR
‘calcitriol’) AND (‘In Vitro Fertilization’ OR ‘Assisted
Table 1 Studies investigating the relationship between vitamin D status and semen parameters in healthy and infertile men
Author,
year, [reference #]
Country Study
design
Cases
included
Sample size Groups of patients identified
by serum 25(OH)D levels
Statistical analysis used Main finding(s) Main
confounding
factors
considered
Ramlau-Hansen
et al., 2011 [29]
USA Cross-
sectional
Healthy men
aged 18-21
307 3-24 ng/ml: low (33.5%)
25–37 ng/ml: medium (33.5%)
38–91: high (33%)
Spearman’s rank
correlation test;
Multivariable linear
regression
No significant association between 25
(OH)D levels and sperm parameters
Season
BMI
History of
diseases
Duration of
abstinence
Time from
ejaculation to
analysis
Blomberg Jensen
et al., 2011 [27]
USA Cross-
sectional
Healthy men
aged 18-21
300 <10 ng/ml: deficient (12%)
10-20 ng/ml: insufficient (32.7%)
21-30 ng/ml : sufficient (41.7%)
>30 ng/ml: high (13.7%)
Kruskal Wallis test;
Multivariable linear
regression
Positive association between 25(OH)D
levels and sperm progressive motility and
morphology
FSH
Duration of
abstinence
Time from
ejaculation to
analysis
Serum calcium
levels
Season
Hammoud et al.,
2012 [30]
USA Cross-
sectional
Healthy men
aged 18-67
147 <20 ng/ml: deficient (12.4%)
20-49 ng/ml: intermediate (75.2%)
≥50 ng/ml: high (12.4%)
Multivariable linear
regression
Negative association of both deficient
and high 25(OH)D levels with sperm
parameters
Season
Age
BMI
Alcohol intake
Smoking
Yang et al.,
2012 [31]
China Cross-
sectional
Healthy and
infertile men
aged 20-40
195 (healthy
group); 364
(infertile group)
<10 ng/ml: severely deficient
10-20 ng/ml: deficient
21-30 ng/ml: insufficient
>30 ng/ml : sufficient
Spearman’s rank
correlation test;
Multivariable linear
regression
Positive association between 25(OH)D
levels, sperm motility and morphology
also in the infertile group
Testosterone
Season
Duration of
abstinence
Time from
ejaculation to
analysis
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ited by language. Clinical trials assessing vitamin D
status of patients undergoing ART and reporting any
association between vitamin D status and IVF/Intracyto-
plasmatic Sperm Injection (ICSI) cycle outcome vari-
ables were considered eligible. The outcomes of interest
for this systematic review included assessment of vita-
min D levels throughout controlled ovarian hyperstimu-
lation (COH), prevalence of vitamin D deficiency among
patients undergoing ART, clinical pregnancy rate (CPR)
and live birth rate (LBR). All pertinent reports were re-
trieved and the relative reference lists were systematic-
ally searched in order to identify any potential additional
studies that could be included. Only those that were
published as full-length articles were considered. Ab-
stracts of scientific meetings were not included [33].
Eligibility assessment and data extraction were performed
independently by two investigators (VSV and PV).
Data extraction
For each study, the following information was extracted:
first author's last name; year of publication; country of
origin; number of subjects; design of the study; statistical
analysis; outcomes assessed; confounding factors consid-
ered; results. The only cycle outcome parameter assessed
in all studies was CPR. Outcome data on CPR were
therefore retrieved from individual reports and pooled
estimation and meta-analysis were performed as follows.
The number of patients who achieved a clinical preg-
nancy among groups of women with and without serum
25(OH)D deficiency (<20 ng/ml) was obtained from each
study and used in the meta-analysis. A clinical preg-
nancy was defined as the observation of an intrauterine
gestational sac following IVF/ICSI procedures and fresh
embryo transfer. In one study [34], patients were divided
into groups based on serum cut-off values that were
different from 20 ng/ml (i.e. three groups based on
serum vitamin D levels <10 ng/ml; 10–29 ng/ml and ≥
30 ng/ml respectively). On the other hand, groups with
<10 ng/ml and ≥30 ng/ml levels could be considered
subgroups of patients with and without vitamin D defi-
ciency respectively and were therefore included in the
meta-analysis. Conversely, the intermediate group [serum
25(OH)D levels 10–29 ng/ml] could not be categorized
neither as vitamin D deficient nor as vitamin D sufficient
and was therefore not considered. Studies categorising pa-
tients only based on follicular fluid (FF) rather than serum
levels of 25(OH)D were excluded from the meta-analysis
in order to contain the heterogeneity.
Statistical analysis
The heterogeneity Cochrane Q and the I2 statistics were
calculated, showing a moderate heterogeneity (I2 = 53%);
for this reason the DerSimonian-Laird random-effectsmodel, which incorporates both within- and between-
study variations was used in the meta-analysis [35,36].
Due to the very low number of studies included in the
meta-analysis, no statistical test for a small-study effect
was conducted [37]. Results are expressed as risk ratio
(RR) with 95% confidence intervals (CIs) [37]. Statistical
significance was set at a p value of <0.05 and analysis
was performed using Review Manager (RevMan, Version
5.2. Copenhagen: The Nordic Cochrane Centre, The
Cochrane Collaboration, 2012).
Results
Figure 1 shows the flow diagram of the complete selec-
tion process following the PRISMA statement [32]. The
database search initially identified 99 articles. Confer-
ence abstracts were excluded (n = 15). Of the 84 full-
length articles, 14 potentially reporting on vitamin D
status with regards to ART outcomes were retrieved for
detailed assessment. After exclusion of seven full length
articles for various reasons (in vitro studies n = 1, re-
views without original data report, n = 6; Figure 1), a
total of seven studies on the association between vitamin
D status of ART patients and IVF/ICSI cycle outcome
variables were identified. Their main methodological
characteristics and findings are presented in Table 2. All
of them were cohort studies. A total of three studies
were conducted in North America, two in Iran, one in
Greece and one in Israel.
Prevalence of vitamin D deficiency among women
undergoing ART procedures
Six cohort studies have characterized serum 25(OH)D sta-
tus in women undergoing ART procedures and addressed
the prevalence of vitamin D deficiency among these pa-
tients [34,38-42] (Table 2). In five studies [38-42], serum
25(OH)D was categorised according to clinically accepted
ranges for vitamin D deficiency (<20 ng/ml), insufficiency
(20–30 ng/ml) and replete (>30 ng/ml) [43]. The observed
prevalence of vitamin D deficiency as defined by serum 25
(OH)D levels <20 ng/m was 21% [41], 26% [42], 27% [38],
31% [39] and 99% [40] respectively in the five studies. In
the study by Firouzabadi et al., vitamin D deficiency was
instead exclusively defined as 25(OH)D levels < 10 ng/ml
[34], and the prevalence of vitamin D deficiency was 75%
with only 7% of patients having replete vitamin D levels
(≥30 ng/ml) [34]. Interestingly, the studies reporting the
highest frequency in vitamin D deficiency (75% for Firou-
zabadi et al., [34] and 99% for Aleyasin et al., [40]) were
both conducted on Iranian women, confirming a strong
influence of the socio-economic factors on vitamin D sta-
tus [44]. After excluding these two studies, the overall
mean prevalence of vitamin D deficiency among the popu-
lation of women who are candidates for IVF procedures
was 25% (21-31%), which is slightly lower than that
Records identified through database 
searching 
(n =99) 
Articles excluded based 
on title and abstract 
(n=70) 
Congress abstracts 
excluded  
(n=15) 
Full-text articles assessed for eligibility 
(n =14) 
Full-text articles excluded 
(n =7) 
Reviews without original data report, 
n=6;  non human studies n=1 
Studies included in 
qualitative synthesis 
(n =7) 
Identification of additional records 
through revision of retrieved 
articles reference lists  
(n=0)
Studies included in 
quantitative synthesis 
(n =3) 
Figure 1 Flow diagram of the complete study selection process.
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women in the USA (36%) [45]. This observation seems
consistent with the demographics of the IVF population,
which tends to have higher socio-economic status and
education level, which are both factors related to higher
vitamin D status [46]. Conversely, the mean observed
prevalence of women with replete vitamin D status [serum
25(OH)D levels > 30 ng/mL] was 34% (range 21-42%
across studies) after excluding the studies by Firouzabadi
et al. [34] and Aleyasin et al. [40].
Vitamin D status and women’s characteristics
Four studies have evaluated baseline characteristics of
patients found to be significantly associated with vitamin
D status, but these studies reported conflicting results
[38-41]. According to Anifandis et al., populations were
homogenous with regards to various patients’ characteris-
tics after grouping for vitamin D status [39]. Conversely,Rudick et al. reported significant differences in age and
BMI between women with and without vitamin D defi-
ciency, with patients affected being younger and with
higher BMI [41]. In addition, Ozkan et al. also noted
an inverse correlation between FF 25(OH)D and BMI
(r = −0.25, p = 0.03) [38], while Aleyasin et al. described
a linear correlation of serum 25(OH)D levels with age
(r = 0.28, p = 0.01) but not with BMI [40]. Three studies
have also investigated the influence of ethnicity on 25
(OH)D levels [38,41,42]. Of the two studies conducted on
conventional IVF populations, one reported Hispanic
whites to have significantly lower serum 25(OH)D levels
compared to Asians and non-Hispanic whites (p = 0.01)
[41] while the other observed, as expected, significantly
lower serum 25(OH)D levels among black versus non-
black ethnicities (p = 0.001) [38]. The study conducted
on recipient women undergoing an oocyte donation pro-
gram reported lower 25(OH)D levels among Asians and
Table 2 Studies investigating the relationship between vitamin D status and outcomes in women undergoing ART treatments
Author,
year, [reference #]
Country Study
design
COH Sample
size
Biological sample(s)
used for 25(OH)D
assessment
Main
Outcomes
Statistical
analysis used
for cycle
outcome
assessment
Main finding(s) Main confounding
factors considered
in the analysis
Potashnik et al.,
1992 [47]
Israel Prospective
cohort
Long agonist
protocol
10 Serum; follicular
fluid (from “one
large follicle”)
Vitamin D
and
metabolites’
levels
throughout
COH
Paired t-test 1,25(OH)2D increased at the end of stimulation.
No changes observed for 25(OH)D, 24,25(OH)2D
None
Ozkan et al.,
2010 [38]
USA Prospective
cohort
Long agonist
protocol
84 Serum; follicular
fluid (pooled from
follicles ≥14 mm)
CPR Multivariate
logistic
regression
FF levels of 25(OH)D act as positive
independent predictor of CPR
Age
Race
BMI
Embryos
transferred (n)
Anifandis et al.,
2010 [39]
Greece Retrospective
cohort
Short agonist
protocol
101 Serum; follicular
fluid (pooled from
all follicles)
Glucose levels
in follicular
fluid; embryo
quality; CPR
X2-test Higher FF levels of 25(OH)D are associated with
lower FF glucose levels and with lower CPR
Age
BMI
Oocytes
retrieved (n)
Aleyasin et al.,
2011 [40]
Iran Prospective
cohort
Long agonist
protocol
82 Serum; follicular
fluid (pooled from
follicles ≥14 mm
after oocyte
isolation)
CPR Multivariate
logistic
regression
No significant association between FF or serum
levels of 25(OH)D and CPR
Variables showing
p value≤ 0.2 on
univariate logistic
regression
Rudick et al.,
2012 [41]
USA Retrospective
cohort
Long agonist;
antagonist;
microdose
flare protocol
188 Serum CPR Multivariate
logistic
regression
Opposite relation between 25(OH)D levels and
IVF outcomes by race: higher levels of 25(OH)D
associated with higher CPR in non-Hispanic
whites and with lower CPR in Asians
Age
BMI
Embryos transferred
(n, quality)
Poor ovarian
reserve
Firouzabadi et al.,
2014 [34]
Iran Prospective
cohort
Long agonist
protocol
221 Serum; follicular
fluid
Chemical
pregnancy
rate
Kruskal-Wallis H
test
No significant association between FF or serum
levels of 25(OH)D and CPR
None
Rudick et al.,
2014 [42]
USA Retrospective
cohort
Egg donation
recipients
99 Serum CPR, LBR Multivariate
logistic
regression
Higher 25(OH)D levels associated with higher
CPR and LBR
Recipient age
Recipient BMI
Embryos transferred
(n, quality)
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white (p = 0.02) [42].
Serum and follicular fluid levels of 25(OH)D
Only one small study conducted sequential measure-
ments of serum vitamin D throughout COH for IVF
in order to identify cycle-related variations [47], and
showed that 1,25-dihydroxyvitamin D concentrations -
but not 25(OH)D and 24,25-dihydroxyvitamin D - pro-
gressively increased throughout COH [47]. Five studies
instead analysed the relationship between serum and
follicular fluid (FF) levels of 25(OH)D [34,38-40,47],
all confirming that a strong positive correlation exists
between peripheral and follicular vitamin D stores
(r = 0.74, p < 0.01 according to Potashnik et al., 1992;
r =0.94; p < 0.001 according to Ozkan et al.; r = 0.79,
p < 0.001 according to Anifandis et al.; r = 0.83, p = 0.001
according to Firouzabadi et al.; r = 0.77, p < 0.001 ac-
cording to Aleyasin et al.). Of note, this observation
seems to suggest that peripheral vitamin D status is a reli-
able indicator for 25(OH)D availability within the ovary.
Vitamin D status in women and IVF outcomes: systematic
review and meta-analysis
The main characteristics and findings of the six studies
that have addressed the role of vitamin D status on IVF/
ICSI outcomes [34,38-42] are shown in Table 2. Two
studies exclusively investigated the association between
FF 25(OH)D levels and ART outcomes. Ozkan et al.
were the first reporting a positive association between
FF 25(OH)D levels and IVF outcomes, with patients in
the highest tertile of FF 25(OH)D distribution being
almost four fold more likely to achieve a clinical preg-
nancy (CP) compared with patients in the lowest tertile
after controlling for potentially confounding factors
[odds ratio (OR) for CP 3.83; 95% CI 1.20 – 12.28,
p = 0.02]. In their study, FF 25(OH)D levels as an inde-
pendent predictor of CP were also confirmed by means
of multivariate logistic regression (confounders-adjusted
OR 1.07; 95% CI 1.01 – 1.13, p = 0.01). In marked con-
trast with these results, Anifandis et al. observed a nega-
tive effect of increasing FF vitamin D levels on IVF
outcomes. Women with higher (>30 ng/ml) FF 25(OH)D
levels showed decreased embryo quality (mean score of
embryo quality 5.6 ± 3.6 vs 7.02 ± 2.5 and 7.96 ± 2.6 re-
spectively, p < 0.05) and reduced CPR (14.3% vs 32.7%
and 32.3% respectively, p < 0.05) compared to patients
with intermediate (20.1-30 ng/ml) or low (≤20 ng/ml) FF
25(OH)D levels. Conflicting observations have also been
derived from the study by Rudick et al. (2012), in which
opposite trends of association were observed according
to patients’ ethnicity. In fact, after dividing the popula-
tion into vitamin D deficient (<20 ng/ml), insufficient
(20–30 ng/ml) and replete (>30 ng/ml) depending onserum 25(OH)D levels, vitamin D status was positively
associated with increasing CPR in non-Hispanic and
Hispanic whites (CPR 21%, 36% and 55% in the defi-
cient, insufficient and replete groups respectively,
p = 0.01, in non-Hispanic whites; CPR increasing from
15%, 38% and 68% in the deficient, insufficient and re-
plete groups respectively, p = 0.03, in Hispanic whites).
In contrast, an opposite inverse relationship between
vitamin D status and IVF success was observed in the
Asian ethnicity (CPR 64%, 34% and 14% in the deficient,
insufficient and replete groups respectively, p = 0.01).
Interestingly, the opposite influence of vitamin D status
on IVF outcome was also confirmed on LBR among
non-Hispanic whites (increasing from 14% in the defi-
cient group to 27% and 47% in the insufficient and
replete groups, respectively, p = 0.01) and Asians (with
LBR decreasing from 53% to 25% and 9% across the vita-
min D deficient, insufficient and replete groups respect-
ively, p = 0.02), but not among Hispanic whites (p = 0.19)
[41]. In a second study, the same authors examined
serum vitamin D levels among n = 99 recipients of
oocyte donation. After dividing patients into vitamin D
deficient (<20 ng/ml), insufficient (20–30 ng/ml) and re-
plete (>30 ng/ml) depending on serum 25(OH)D levels,
the authors observed a significant increase in both CPR
(37%, 37% and 78% respectively, p = 0.004) and LBR
(31%, 30% and 59% respectively, p = 0.04) across the
three groups, suggesting a specific effect of 25(OH)D
levels on IVF outcomes to be mediated by endometrial
receptivity [42]. However, a recent study by Firouzabadi
et al., showed increased fertilization rates across
groups based on serum vitamin D status. In detail, the
fertilization rates associated with serum vitamin D defi-
ciency (<10 ng/ml), insufficiency (10–29 ng/ml) and
sufficiency (30–100 ng/ml) were 43%, 53%, and 59%, re-
spectively (p = 0.05). Of note, no statistical significance
was reached and vitamin D status was in general low in
the population studied - with only 7% of women being
vitamin D sufficient [34]. Similarly, results from the
study by Aleyasin et al., which showed that CPR did not
change significantly across groups based on increasing
tertiles of FF vitamin D levels (29%, 30% and 30% re-
spectively, p = 0.9) are difficult to interpret because all
women in the population except for one (n = 81/82)
were vitamin D deficient in the serum [40].
When pooling data for meta-analysis, data on the ef-
fect of vitamin D serum deficiency (<20 ng/ml) on CPR
after IVF/ICSI procedures were extracted [34,40-42].
Categorisation of patients was not possible in the study
by Aleyasin et al. due to the fact that all patients except
for one were deficient [40]. Overall, the remaining three
studies account for n = 353 women undergoing IVF/ICSI
procedures and fresh embryo transfer, of which n = 115
were vitamin D deficient [as defined by serum 25(OH)D
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[serum 25(OH)D levels ≥20 ng/ml]. Results are shown
in Figure 2. A clinical pregnancy was achieved in 46/115
(40%) women with vitamin D deficiency, and in 109/238
(46%) in those with sufficient serum 25(OH)D levels.
The RR of clinical pregnancy ranged from 0.60 to 1.84
[48,49] across studies, and pooling of the results yielded
a common RR of 0.89 (95% CI 0.53 to 1.49), showing
a lower but not statistically significant likelihood of CP
for vitamin D deficient women undergoing IVF/ICSI
procedures compared with vitamin D sufficient patients
(Figure 2).
Vitamin D status in men and ART outcomes
No data are currently available regarding vitamin D and
semen performance in regards to clinical outcomes in-
cluding fertilization rate, embryo quality, pregnancy rate
and LBR in the context of IVF treatments. Further stud-
ies conducted on spermatozoa from infertile men are
utterly needed to allow the identification of a potential
role of vitamin D in influencing treatment outcomes for
couples undergoing IVF for male factor infertility. Of
note, based on the available data in infertile men in gen-
eral, there is an ongoing randomized controlled trial
(RCT) by Blomberg Jensen’s group (ClinicalTrials. gov
Identifier: NCT01304927) testing the benefits of vitamin
D supplementation on semen parameters.
Comments
The issue of whether vitamin D levels are reliable pre-
dictors of ART outcomes is still controversial. Evidence
is still poor, because no RCTs are currently available
and results of existing small cohort studies are very het-
erogeneous. Consequently, the meta-analysis performed
herein fails to identify a significant association between
vitamin D status and CPR after ART. Marked differences
in exposure categorisation, analytic approaches, out-
comes considered and general methodological design
characterize the identified studies. More specifically:Figure 2 Forest plot of meta-analysis results. Included studies account for
women with vitamin D deficiency, and in 109/238 (46%) in those with sufficie
showing a lower but not statistically significant likelihood of CP for vitamin D
vitamin D sufficient patients. Please note that in the study by Firouzabadi et al.
10 ng/ml while all those with sufficient serum 25(OH)D levels had serum 25(OH)
RR = Risk Ratio.1. Main outcomes varied greatly among the various
studies including both biological and clinical
outcomes such as embryo parameters and
pregnancy rates.
2. A matter of concern may be the threshold used to
define insufficiency. The commonly accepted cut-off
value for vitamin D deficiency [serum 25(OH)D <
20 ng/ml] has been established based on bone
health in the general population, and may not be
appropriate to the peri-conceptional period, with
some authors proposing that circulating levels of 25
(OH)D should be as high as 40–60 ng/ml during
gestation [48]. Therefore, a higher availability of
vitamin D as compared to the standard cut-off value
of 20 ng/ml might also be required in the population
of infertile couples undergoing IVF, and further
analysis of the critical threshold for serum 25(OH)D levels
with regards to the peri-conceptional period is needed.
3. Some clinical conditions that are commonly
encountered among IVF candidates (including
younger or older age, higher BMI, PCOS,
endometriosis, and uterine leiomyomas) have been
related to significantly altered serum 25(OH)D
levels. These conditions are also associated with
relevant differences in prognosis with regards to IVF
outcomes. While the potential confounders
represented by age and BMI can be mostly excluded
because all studies properly controlled for both
covariates in their statistical analyses (with the only
exception of Firouzabadi et al. who did not report
any data on patients’ BMI), most of the available
studies do not give sufficient information to exclude
potential biases caused by the different prevalence of
the other factors (e.g. PCOS, endometriosis, and
uterine leiomyomas).
4. Not all the currently available studies have
controlled for potential confounders affecting
implantation and pregnancy rates such as the
number and quality of embryos transferred.n = 353 women. A clinical pregnancy was achieved in 46/115 (40%)
nt serum 25(OH)D levels, yielding a RR of 0.89 (95% CI 0.53 to 1.49)
deficient women undergoing IVF/ICSI procedures compared with
all patients with vitamin D deficiency had serum 25(OH)D levels <
D levels > 30 ng/ml. CI = confidence interval. M-H =Mantel-Haenszel.
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assessment among studies as demonstrated by
measurement variability and large discrepancies in
concentrations observed in different laboratories [49].
6. Finally, relevant factors such as duration of vitamin
D deficiency or source of vitamin D (previous
supplementation, sun exposure and diet) [43] have
never been investigated in any of the studies.
Due to the presence of several sources of controversy
in the interpretation of the relationship between vitamin
D deficiency and poor IVF outcome, we have employed
the nine criteria proposed by Austin Bradford Hill,
which still stand as foundation milestones for addressing
causation conditions [50]. Five (“specificity“, “temporal-
ity“, “biological plausibility“, “experimental evidence“,
“analogy“) out of nine Hill’s criteria for causality are in-
deed fulfilled, two (“consistency” and “biological gradi-
ent”) are fulfilled by all currently available studies except
for one, while the “specificity” criterion cannot be deter-
mined due to insufficient data and the “strength of asso-
ciation” criterion is not fulfilled likely due to the small
sample size of the studies and the low magnitude of the
effect. Hence, according to the Hill’s criteria, a causal re-
lationship between vitamin D deficiency and negative
outcomes should be recognised, but further research is
needed to determine the strength of the association and
the specific underlying mechanisms [50].
In summary, consistent heterogeneity exists among
available studies and important factors need to be con-
sidered in this regard such as insufficient sample size,
ethnicity, BMI, countries of origin, socio-economic sta-
tus and the presumably mild magnitude of the effects.
This latter aspect should however not disregard the po-
tential relevance of vitamin D status in an IVF setting
for two main reasons. Firstly, there is growing evidence
that maternal vitamin D status may influence pregnancy
outcome, with consistent evidence demonstrating a role
of vitamin D insufficiency in pre-eclampsia and preterm
birth [5]. Albeit less robust, there is also some data sug-
gesting a relationship with gestational diabetes mellitus
and late growth restriction [5]. Hence, the relevance of
an advantage of vitamin D sufficiency in increasing the
chances of pregnancy in IVF cycles would be strength-
ened by the potential, subsequent advantage in terms of
improvements in obstetrics complications and neonatal
health even if the magnitude of the effect is still to be
measured [51]. Secondly, vitamin D deficiency or insuffi-
ciency is easily amenable to correction. Oral vitamin D
supplementation at therapeutic doses is indeed a simple
and cheap intervention without significant side effects.
Importantly, recent studies have shown that maternal
supplementation with vitamin D during second and
third-trimester pregnancy at doses up to 4000 IU is safeand can effectively improve maternal vitamin D status
[52]. However, results of the ongoing RCTs on vitamin
D supplementation prior to IVF procedures are not yet
available.
Conclusions
Our meta-analysis suggests that vitamin D status assess-
ment and supplementation prior to IVF is currently not
recommended. Further studies on this topic are re-
quired. In fact, despite a trend for a negative effect of
vitamin D deficiency on ART outcomes, results are still
controversial and large cohort studies properly adjusting
for confounders are required to assess the influence of
vitamin D deficiency and to properly estimate the mag-
nitude of the effect. If confirmed, RCTs will be necessary
to establish future indications for routine assessment of
vitamin D status and supplementation prior to ART.
Interestingly, Lindqvist and colleagues are currently test-
ing the effects of high (1000 IU) and low (500 IU) dose
vitamin D supplementation on 1000 women initiating
IVF treatment in Sweden in the registered prospective
double-blind randomised trial entitled “Vitamin D dur-
ing IVF” [ClinicalTrials.gov: NCT01019785], but results
are still not available. On the other hand, there is the
need for independent trials in different populations as
the benefits of supplementation may markedly differ
among populations.
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